Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
1dmw | HBI | Phenylalanine-4-hydroxylase | 1.14.16.1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
1dmw | HBI | Phenylalanine-4-hydroxylase | 1.14.16.1 | 1.000 | |
1lrm | HBI | Phenylalanine-4-hydroxylase | 1.14.16.1 | 0.659 | |
1tg2 | H2B | Phenylalanine-4-hydroxylase | 1.14.16.1 | 0.609 | |
1j8u | H4B | Phenylalanine-4-hydroxylase | 1.14.16.1 | 0.578 | |
3pah | XDE | Phenylalanine-4-hydroxylase | 1.14.16.1 | 0.576 | |
2toh | HBI | Tyrosine 3-monooxygenase | 1.14.16.2 | 0.573 | |
4pah | LNR | Phenylalanine-4-hydroxylase | 1.14.16.1 | 0.545 | |
5pah | LDP | Phenylalanine-4-hydroxylase | 1.14.16.1 | 0.537 | |
1mmk | H4B | Phenylalanine-4-hydroxylase | 1.14.16.1 | 0.501 | |
1kw0 | H4B | Phenylalanine-4-hydroxylase | 1.14.16.1 | 0.486 | |
1v3q | 2DI | Purine nucleoside phosphorylase | 2.4.2.1 | 0.473 | |
2q1s | NAI | Putative nucleotide sugar epimerase/ dehydratase | / | 0.466 | |
2uxo | TAC | HTH-type transcriptional regulator TtgR | / | 0.466 | |
4bfx | ZVX | Pantothenate kinase | 2.7.1.33 | 0.466 | |
3p62 | FMN | Pentaerythritol tetranitrate reductase | / | 0.460 | |
2zu9 | GDP | Mannosyl-3-phosphoglycerate synthase | 2.4.1.217 | 0.459 | |
3b8x | G4M | Putative pyridoxamine 5-phosphate-dependent dehydrase | / | 0.459 | |
4ddr | MMV | Dihydrofolate reductase | 1.5.1.3 | 0.458 | |
4hbm | 0Y7 | E3 ubiquitin-protein ligase Mdm2 | 6.3.2 | 0.457 | |
4m0f | 1YK | Acetylcholinesterase | 3.1.1.7 | 0.457 | |
4nv1 | 0FX | Formyl transferase | / | 0.457 | |
5dp2 | NAP | CurF | / | 0.456 | |
2vn1 | FK5 | Peptidylprolyl isomerase | / | 0.455 | |
3zhq | TPP | Multifunctional 2-oxoglutarate metabolism enzyme | 1.2.4.2 | 0.455 | |
2zev | IPE | Geranylgeranyl pyrophosphate synthase | / | 0.454 | |
2xvi | FAD | Putative flavin-containing monooxygenase | / | 0.453 | |
3nyt | ULP | UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase | 2.6.1.98 | 0.453 | |
2a57 | CRM | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.452 | |
1h22 | E10 | Acetylcholinesterase | 3.1.1.7 | 0.451 | |
3bxo | UPP | dTDP-3-amino-3,4,6-trideoxy-alpha-D-glucopyranose | / | 0.451 | |
4j7h | TRH | PCZA361.3 | / | 0.451 | |
1p5r | COA | Formyl-CoA:oxalate CoA-transferase | / | 0.449 | |
2our | CMP | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.449 | |
4b66 | NAP | L-ornithine N(5)-monooxygenase | / | 0.449 | |
5hwq | CAA | Hydroxymethylglutaryl-CoA synthase | / | 0.449 | |
2cek | N8T | Acetylcholinesterase | 3.1.1.7 | 0.448 | |
3nmp | PYV | Abscisic acid receptor PYL2 | / | 0.448 | |
1h50 | FMN | Pentaerythritol tetranitrate reductase | / | 0.447 | |
1h51 | FMN | Pentaerythritol tetranitrate reductase | / | 0.447 | |
2gvd | FKP | Adenylate cyclase type 2 | / | 0.447 | |
2gvd | FKP | Adenylate cyclase type 5 | / | 0.447 | |
2hxz | H7J | Cathepsin S | 3.4.22.27 | 0.447 | |
2po3 | T4K | 4-dehydrase | / | 0.447 | |
3nub | UD0 | UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase | 2.6.1.98 | 0.447 | |
4g2y | NI5 | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.447 | |
4yfy | 0FX | VioF | / | 0.447 | |
2z4s | ADP | Chromosomal replication initiator protein DnaA | / | 0.446 | |
3jsw | JAR | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.446 | |
3n3z | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.446 | |
4e90 | 7RG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.446 | |
4uug | PXG | Branched-chain amino acid aminotransferase, putative | / | 0.446 | |
3ndc | SAH | Precorrin-4 C(11)-methyltransferase | 2.1.1.133 | 0.445 | |
3c49 | KU8 | Poly [ADP-ribose] polymerase 3 | 2.4.2.30 | 0.444 | |
4b1r | ITC | Tetracycline repressor protein class D | / | 0.444 | |
4ms1 | 381 | Gamma-aminobutyric acid type B receptor subunit 1 | / | 0.444 | |
3ai0 | PNW | Beta-glucosidase | / | 0.443 | |
4epl | JAI | Jasmonic acid-amido synthetase JAR1 | 6.3.2 | 0.443 | |
1lwi | NAP | 3-alpha-hydroxysteroid dehydrogenase | 1.1.1.50 | 0.442 | |
1qvt | PRL | HTH-type transcriptional regulator QacR | / | 0.442 | |
1y2c | 3DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.442 | |
2j3j | HC4 | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.442 | |
2pks | G44 | Prothrombin | 3.4.21.5 | 0.442 | |
3fr5 | I4A | Fatty acid-binding protein, adipocyte | / | 0.442 | |
1r58 | AO5 | Methionine aminopeptidase 2 | / | 0.441 | |
1t5b | FMN | FMN-dependent NADH-azoreductase | / | 0.441 | |
1v2h | GUN | Purine nucleoside phosphorylase | 2.4.2.1 | 0.441 | |
2y60 | M8F | Isopenicillin N synthase | 1.21.3.1 | 0.441 | |
3ed1 | GA3 | Gibberellin receptor GID1 | / | 0.441 | |
3hgo | FMN | 12-oxophytodienoate reductase 3 | 1.3.1.42 | 0.441 | |
3k3h | BYE | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.441 | |
3sqx | ANP | ATP-dependent RNA helicase MSS116, mitochondrial | 3.6.4.13 | 0.441 | |
4bft | ZVT | Pantothenate kinase | 2.7.1.33 | 0.441 | |
1lkd | BP6 | Biphenyl-2,3-diol 1,2-dioxygenase | 1.13.11.39 | 0.440 | |
1pqc | 444 | Oxysterols receptor LXR-beta | / | 0.440 | |
3c4h | DRL | Poly [ADP-ribose] polymerase 3 | 2.4.2.30 | 0.440 | |
3jsi | WTC | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.440 | |
4z63 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.440 |